الفهرس | يوجد فقط 14 صفحة متاحة للعرض العام |
المستخلص The present study suggested that aliskiren, a direct renin inhibitor (DRI), is used as an effective antihypertensive therapy both as monotherapy and in combination with more conventional blockers of the renin-angiotensin-aldosterone system (RAAS). Aliskiren monotherapy (75–300 mg/day) . |